Japanese encephalitis (JE)
Japanese encephalitis (JE), the leading cause of viral encephalitis in Asia, causes an estimated 30,000 to 50,000 cases and 10,000 to 15,000 deaths each year, mostly among children under 15 years of age. There is no specific treatment for JE. Vaccination is the single most important measure for controlling the disease.
JE resources on the Vaccine Resource Library were mainly gathered during PATH’s JE project, which conducted technical activities from 2003 to 2009 in collaboration with local, regional, and global health stakeholders. For additional resources, visit the JE page on the World Health Organization website.
More about JE | View resources on JE
Key resources
Report on the Japanese Encephalitis Disability Assessment (2008)
An assessment conducted in Cambodia that found one in four children infected with JE either died or suffered severe sequelae.
Effectiveness of One Dose of SA 14-14-2 Vaccine Against Japanese Encephalitis (2009)
A letter to a scientific journal about a small case control study in India on the efficacy of a single dose of the SA 14-14-2 JE vaccine.
Featured PATH resources
More About Japanese Encephalitis (JE) (2011)
A web page that provides a link to PATH's work on JE, as well as general information about the disease and its current vaccine landscape.
Japanese Encephalitis Morbidity, Mortality, and Disability: Reduction and Control by 2015 (2009)
A strategic plan that provides details on priority activities that must be sustained for continued momentum in JE control.
Page last updated: December 2012.
